Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice

Journal of Lipid Research

Volumn 42, Issue 1, 2001, Pages 41-50

  Bloks, Vincent W ^a   Plösch, Torsten ^a   Van Goor, Harry ^a   Roelofsen, Han ^a   Baller, Juul ^a   Havinga, Rick ^a   Verkade, Henkjan J ^a   Van Tol, Aad ^b   Jansen, Peter L M ^a   Kuipers, Folkert ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Bile; Bile salt; Cholesterol; High density lipoprotein; Lipoprotein X; mdr2 P glycoprotein; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; BILE SALT; CHOLESTEROL; FERROCHELATASE; GLYCOPROTEIN P; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN X; MESSENGER RNA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BILE DUCT; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ERYTHROPOIETIC PROTOPORPHYRIA; HYPERLIPIDEMIA; LIPID METABOLISM; LIVER DISEASE; LIVER MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ARTERIOSCLEROSIS; FATTY LIVER; FERROCHELATASE; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPIDS; LIPOPROTEIN-X; LIPOPROTEINS, HDL; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PROTOPORPHYRIA, ERYTHROPOIETIC;

EID: 0035136863     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The porphyrias
2. Erythropoietic protoporphyria
3. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria
4. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation
5. Elevated plasma triglyceride levels are associated with human protoporphyria
6. Erythropoietic protoporphyria in the house mouse
7. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria
8. Impaired secretion of very low density lipoprotein-triglyceride secretion in apolipoprotein E-deficient mice
9. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice
10. Very fast ultracentrifugation of serum lipoproteins: Influence on lipoprotein separation and composition
11. A rapid method of total lipid extraction and purification
12. A rapid and sensitive submicro-phosphorus determination
13. ACAT-2, a second mammalian acyl-CoA: Cholesterol acyltransferase. Its cloning, expression and characterization
14. Molecular cloning and nucleotide sequence of cDNA encoding a functional routine low-density-lipoprotein receptor
15. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a
16. A rapid and versatile method to synthetize internal standards for competitive PCR
17. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase
18. Different locations of cholesteryl ester transfer protein and phospholipid transfer proteins in plasma
19. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as wel as in normotriglyceridaemic patients with type 2 diabetes
20. 3-HydroxTy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce expression of the phospholipid translocase mdr2 P-glycoprotein in rats
21. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse
22. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liven
23. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liven
24. Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts
25. Abnormal lipid composition of microsomes from cirrhotic rat liver - Does it contribute to decreased microsomal function?
26. Secretion of lipoprotein-X by perfused livers of rats with cholestasis
27. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects
28. Familial lecithin:cholesterol acyltransferase deficiency: Further resolution of lipoprotein particle heterogeneity in the low density interval
29. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and liver disease
30. Mechanisms and (patho)physiological significance of biliary cholesterol secretion
31. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport
32. Regulation of mdr2 P-glycoprotein expression by bile salts
33. Influence of bile salts on molecular interactions between sphingomyelin and cholesterol: Relevance to bile formation and stability
34. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification
35. Lipoprotein X fails to inhibit hydroxymethylglutaryl coenzyme a reductase in HepG2 cells
36. Role of lipoprotein X in the pathogenesis of cholestatic hypercholesterolemia